SHANGHAI, March 19 (Reuters) - AstraZeneca said on Thursday it will build a cell therapy manufacturing and supply base and an innovation centre in Shanghai, aiming to become the first global drugmaker ... ( read original story ...)
Global market watch | China stocks dip to six-week low as Middle East conflict escalates
Asian stocks, including China and Hong Kong, experienced a significant downturn on Thursday due to escalating Iran conflict and its impact on global risk appetite. The Shanghai Composite and CSI300 ... ( read original story ...)
Book your tickets and pack your bags – we’re heading to Shanghai
Shanghai is on the up. Monocle’s new conference will bring together founders and business leaders in the city for ... ( read original story ...)
Shanghai and Hong Kong Deepen Filmmaking Collaboration With Formal Agreement at FilMart
The Shanghai Broadcasting Film & TV Producers Assn. and the Hong Kong Screenwriters’ Guild formally signed an agreement to deepen cooperations on March 19 at FilMart. The Memorandum of Understanding, ... ( read original story ...)
Antonelli’s Shanghai win showed how far he’s come, and proved Mercedes was right to have faith
The Italian teenager followed his first pole with a maiden win in China. ( read original story ...)
Shanghai’s invasive BMI medical device gets nod
An implantable brain-machine interface system for hand movement compensation developed by a Shanghai company has become the world's first invasive BMI medical device to gain market approval, marking ... ( read original story ...)
KWEB China ETF: Navigating Volatility As Positive Catalysts Mount
KWEB’s relative strength index reached the second-lowest level in its history on March 3, 2026, and remains near 30, a level typically described as 'oversold'. ( read original story ...)